Pro-Life Groups Raise Alarm Over Delayed FDA Review of Abortion Pill Safety
Pro-life organizations and advocates called for the FDA Commissioner to be fired this week over the failure of FDA health officials to review abortion pill safety.
The abortion pill is a two-step process. The first pill, mifepristone, prohibits a baby’s further development and eventually starves it. The second pill, misoprostol, expels the baby from the mother’s body.
As reported by the Daily Citizen, in May, the Ethics and Public Policy Center released a study revealing nearly 11% of women who take the pill experience serious adverse effects, including sepsis, hemorrhaging, infection, and emergency room visits.
That is 22 times higher than the FDA’s current label, which suggests the rate of adverse effects is only 0.5%.
When Senator Josh Hawley addressed the study with Health and Human Services Secretary Robert Kennedy at a senate hearing later that month, Secretary Kennedy acknowledged the data was “alarming” and pledged HHS would perform a “complete review” of mifepristone.
Since May, the FDA has not completed a review of mifepristone, and instead approved a generic version of the drug at the end of September.
In a post on X, Senator Hawley called the approval “shocking.” He declared:
Now, Susan B. Anthony Pro-Life America claims FDA leadership intentionally slow-walked the promised review of mifepristone and is calling for the FDA Commissioner Marty Makary to be fired.
Senator Hawley recently released his letter to the FDA Commissioner, calling on the agency to stop stonewalling the review and reinstate the mifepristone safety protocols instated during the first Trump Administration.
Live Action’s President Lila Rose called on the FDA to act immediately to protect children and mothers from mifepristone.
To date, the White House and Department of Health and Human Services deny slow-walking the review and maintain it simply takes time.
For now, mifepristone and its generic counterpart remain available to the public under existing FDA authority, and no leadership changes have been announced. But there is growing pressure for the FDA to complete the promised safety review.
Some women, after taking the first abortion pill (mifepristone), come to regret their decision. Thankfully, there is a way to reverse the pill’s effects if prompt action is taken.
To learn more about the abortion pill reversal protocol, visit abortionpillreversal.com or call 1-877-558-0333 to be connected with a medical professional who can guide callers through the process of reversing the pill’s effects.
Additionally, if you’re struggling and need a listening ear, Focus on the Family offers a free, one-time counseling consultation with a licensed or pastoral counselor. To request a counseling consultation, call 1-855-771-HELP (4357) or fill out our Counseling Consultation Request Form.
Related articles and resources:
RFK Jr. Announces ‘Complete Review’ of Abortion Pill After ‘Alarming’ New Study Reveals Dangers
Louisiana, ADF Challenge Biden-Era Abortion-By-Mail Scheme
FDA Approves Generic Abortion Pill Despite Ongoing Safety Review
Become an Option Ultrasound Life Advocate
Dealing With an Unplanned Pregnancy
New Insights on the Dangers of the Abortion Pill
ABOUT THE AUTHOR
